Get the Stockscreener App
2.02
1.47%
-0.02
Cardio Diagnostics Holdings Inc stock is traded at $2.02, with a volume of 24,999.
It is down -1.47% in the last 24 hours and up +16.86% over the past month.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
See More
Previous Close:
$2.04
Open:
$2
24h Volume:
24,999
Relative Volume:
0.38
Market Cap:
$5.98M
Revenue:
$16,600
Net Income/Loss:
$-6.65M
P/E Ratio:
-0.5985
EPS:
-3.3752
Net Cash Flow:
$-6.32M
1W Performance:
+17.54%
1M Performance:
+16.86%
6M Performance:
+68.91%
1Y Performance:
-44.63%
1-Day Range:
$1.98
$2.10
1-Week Range:
$1.58
$2.34
52-Week Range:
$0.97
$7.91
Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile
Name
Cardio Diagnostics Holdings Inc
Sector
Industry
Phone
855-226-9991
Address
311 W. SUPERIOR STREET, CHICAGO
Compare CDIO vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDIO
Cardio Diagnostics Holdings Inc
|
2.019 | 6.04M | 16,600 | -6.65M | -6.32M | -3.3752 |
VRTX
Vertex Pharmaceuticals Inc
|
515.27 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
806.54 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
992.75 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
215.57 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.12 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News
Cardio Diagnostics Holdings Inc (CDIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cardio Diagnostics Holdings, Inc. 2026: Revenue $5.36K, EPS ($0.51) — 10-Q Summary - TradingView
Cardio Diagnostics (NASDAQ: CDIO) Q2 2026 shows $5.6M cash and equity funding - Stock Titan
Cardio Diagnostics Holdings Inc (CDIO) Stock News Today - TradingKey
CDIO | Cardio Diagnostics Holdings Inc. Executive Compensation - Quiver Quantitative
Cardio Diagnostics (NASDAQ: CDIO) plans vote on sizable new stock issuance - Stock Titan
Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026 - Business Wire
Enterprise value to EBITDA forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView
CDIOW Warrants Hold at $0.01 as Cardio Diagnostics Faces a Critical Technical FloorDiamond Pattern - dars.gov.et
Cardio Diagnostics Holdings Inc (CDIO) Income Statement - tradingkey.com
Cardio Diagnostics Holdings Inc. Revenue Breakdown – BOATS:CDIOW - TradingView
CDIO|Cardio Diagnostics Holdings Inc|Price:1.600|Chg%:+0.050 - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Balance Sheet - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cardio Diagnostics Holdings Inc. Revenue Breakdown – NASDAQ:CDIOW - TradingView
CDIO|Cardio Diagnostics Holdings Inc|Price:1.550|Chg%:-0.050 - TradingKey
Cardio Diagnostics Hldgs Market Sentiment - Benzinga España
Cardio Diagnostics Holdings Inc (CDIO) Institutional Confidence - TradingKey
Cardio Diagnostics Warrants See Significant Gains (CDIOW) – A Closer LookVOLD Alert - dars.gov.et
Cardio Diagnostics Holdings Inc (CDIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cardio Diagnostics (CDIO) details AI-driven heart disease testing and capital raises - Stock Titan
CDIO Q1 2025 Earnings: Narrower-Than-Expected Loss but Revenue Remains AbsentStrong Earnings Momentum - dars.gov.et
Cardio Diagnostics Holdings Inc. (CDIO) Q1 2025 Earnings: Better-than-Expected Losses but No Revenue YetEPS Growth Rate - dars.gov.et
Cardio Diagnostics Holdings Inc. Warrant (CDIOW) Surges Over 31% but Remains at Sub-Penny LevelsRating Change - dars.gov.et
What's Driving Cardio Diagnostics Holdings' Recent Stock Surge - Kavout | AI
Cardio Diagnostics Leverages AI and Precision Medicine to Address Growing Cardiovascular Disease Market - citybuzz -
Price to book forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView
Cardio Diagnostics (NASDAQ: CDIO) eyes private share issuance of up to $10M - Stock Titan
Price to earnings forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView
Enterprise value to EBIT forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView
Heart Attack Diagnostic Market Report Examines Leading Companies And Growth Opportunities - openPR.com
Enterprise value to revenue forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIO - TradingView
CDIO Q1 2025 Earnings: Narrower-than-Expected Loss Despite Stock PullbackDividend Growth Analysis - DonanımHaber
CDIO Should I Buy - Intellectia AI
Form 4 Cardio Diagnostics Holdings Inc For: 2 July By Investing.com - Investing.com India
Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19 strike - Stock Titan
Cardio Diagnostics (NASDAQ: CDIO) director awarded 2,854 options at $2.19 - Stock Titan
Cardio Diagnostics (CDIO) director granted 2,854 stock options at $2.19 strike price - Stock Titan
Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19 - Stock Titan
Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans - NewMediaWire
Cardio Diagnostics Holdings (NASDAQ: CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans - Barchart.com
CDIO Q1 2025 Earnings: EPS Beats Estimates by 47.2% as Company Advances Diagnostic PlatformAnalyst Coverage Count - dars.gov.et
Cardio Diagnostics Highlights Precision Cardiovascular Tools for Employers and Health Plans at National Conferences - citybuzz -
Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks - TradingView
Cardio Diagnostics Uses Epigenetics to Uncover Hidden Heart Disease Risks - MEXC
Cardio Diagnostics Holdings (CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection - TipRanks
Cardio Diagnostics Holdings Warrant (CDIOW) Holds Steady at $0.01 Amid Minimal MovementValue Area Low - dars.gov.et
Cardio Diagnostics Holdings Inc Stock (CDIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.24%
1.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):